The 150-patient trial has problems of confounding, according to two experts, and is unable to answer definitively whether hydroxychloroquine can benefit COVID-19 patients or harm them.
Problem solver. Creator. Thinker. Web nerd. Food enthusiast. Pop culture junkie. Snowboarder, dreamer, hiphop head, hand letterer and growthhacker. Producing at the crossroads of modernism and programing to express ideas through design. I am 20 years old.
July 20, 2020
April 1, 2020